Medical Advocates
HIV Infection/Disease
  Lactic Acid Alterations/Disorders
 		  
Hyperlactatemia
 Lactic Acidosis
 
 
HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  
Last Update: October 13, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Hyperlactatemia
       

      Journal Papers, Abstracts, and Commentaries

 
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
Feeney E, Chazallon C, O’Brien N, et al
HIV Med. 2011 May 22.
 Abstract

‘FULL-TEXT ARTICLE
 A Risk-Factor Guided Approach to Reducing Lactic Acidosis and Hyperlactatemia in Patients on Antiretroviral Therapy.
Matthews LT, Giddy J, Ghebremichael M,  et al 
PLoS One. 2011 Apr 11;6(4):e18736.
Paper

Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis.
Arenas-Pinto A, Grant A, Bhaskaran K, et al
Antivir Ther. 2011;16(2):219-226.
 Abstract
 
           Conference Reports, Abstracts, and Posters
 
  Hyperlactataemia is a common complication of antiretroviral therapy in children in rural Mopani District, South Africa
M. van Ramshorst, H. Struthers, J.A. McIntyre, R.P.H. Peters
 (XIX International AIDS Conference)
 Abstract

Lactic Acidosis
       

      Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
 A Risk-Factor Guided Approach to Reducing Lactic Acidosis and Hyperlactatemia in Patients
on Antiretroviral Therapy.
Matthews LT, Giddy J, Ghebremichael M,  et al 
PLoS One. 2011 Apr 11;6(4):e18736.
Paper

Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis.
Arenas-Pinto A, Grant A, Bhaskaran K, et al
Antivir Ther. 2011;16(2):219-226.
 Abstract
HIV Metabolic Disorders Main Page   Main New/Newsworthy Home Page  

Lactic Acid Alterations/Disorders